EGFR and pancreatic adenocarcinoma: Enhanced AGR2 expression and activated EGFR signaling is present in all pancreatic adenocarcinomas, chronic pancreatitis, and premalignant pancreatic intraepithelial neoplasias [49, 52, 53].